BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:REQUEST X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:W. Europe Standard Time BEGIN:STANDARD DTSTART:16011028T030000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10 TZOFFSETFROM:+0200 TZOFFSETTO:+0100 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010325T020000 RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3 TZOFFSETFROM:+0100 TZOFFSETTO:+0200 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT ATTENDEE;CN="Stierli, Peter";RSVP=TRUE:mailto:Peter.Stierli@siegfried.ch ATTENDEE;CN="Neukamm, Olivia";RSVP=TRUE:mailto:Olivia.Neukamm@siegfried.ch ATTENDEE;CN="Lehman, Madison";RSVP=TRUE:mailto:Madison.Lehman@siegfried.ch CLASS:PUBLIC CREATED:20250829T082135Z DESCRIPTION:From lab to launch: Cutting time in pharmaceutical development\ n\nIn an industry where drug development often spans over a decade\, accel erating timelines is critical—not only to reduce costs but to improve pa tient access to life-saving therapies. This session explores strategies to streamline the development phase without compromising on safety or qualit y. Join Stefan Randl\, CSO Siegfried\, to learn how smarter\, faster devel opment is both achievable and essential.\n\n \n\nSpeaker: Stefan Randl\, C hief Scientific Officer at Siegfried\n\n \n\n DTEND;TZID="W. Europe Standard Time":20251029T141000 DTSTAMP:20250829T080338Z DTSTART;TZID="W. Europe Standard Time":20251029T134500 LAST-MODIFIED:20250829T082135Z LOCATION:CPHI Future of Pharma & Ingredients Theatre: Hall 12.1 - 12.1C68 ORGANIZER;CN="Siegfried Communications":mailto:communications@siegfried.ch PRIORITY:5 SEQUENCE:1 SUMMARY;LANGUAGE=de-ch:From lab to launch: Cutting time in pharmaceutical d evelopment TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E008000000003024CCB6C818DC01000000000000000 0100000006B14A8EC25F88C40935EF78E6FF112DE X-ALT-DESC;FMTTYPE=text/html:

From lab to launch: Cutting time in pharmaceutical development

In an industry where drug development often spans over a decade\, accelerating timelines is critical—\;not only to reduce costs but to improve patient access to life-saving therapies. This session explores strategies to streamline the development phase without compromising on safety or quality. Join Stef an Randl\, CSO Siegfried\, to learn how smarter\, faster development is bo th achievable and essential.

 \;

Speaker: Stefan Randl\, Chief Scientific Officer at Siegfried

 \;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-APPTLASTSEQUENCE:1 X-MS-OLK-APPTSEQTIME:20250829T080338Z X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR